-
ICD-10-CM Codes
›
-
E00-E89
›
-
E70-E88
›
-
E70-
›
-
2023 ICD-10-CM Diagnosis Code E70.329
2023 ICD-10-CM Diagnosis Code E70.329
Oculocutaneous albinism, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- E70.329 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM E70.329 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E70.329 - other international versions of ICD-10 E70.329 may differ.
The following code(s) above
E70.329 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
E70.329:
- E00-E89
2023 ICD-10-CM Range E00-E89
Endocrine, nutritional and metabolic diseasesNote- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Type 1 Excludes- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
- E70-E88
2023 ICD-10-CM Range E70-E88
Metabolic disordersType 1 Excludes- androgen insensitivity syndrome (E34.5-)
- congenital adrenal hyperplasia (E25.0)
- hemolytic anemias attributable to enzyme disorders (D55.-)
- Marfan's syndrome (Q87.4)
- 5-alpha-reductase deficiency (E29.1)
Type 2 Excludes- Ehlers-Danlos syndromes (Q79.6-)
- E70.32
ICD-10-CM Diagnosis Code E70.32
Oculocutaneous albinism
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- An autosomal recessive inherited disorder caused by mutations of the oca2, slc45a2, tyr and tyrp1 genes. It is characterized by hypopigmentation of the skin, hair, and eyes, resulting in very fair skin, white colored hair, and reduced pigmentation in the iris and retina. Individuals may have vision disturbances and photophobia.
- Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.
ICD-10-CM E70.329 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 642 Inborn and other disorders of metabolism
Convert E70.329 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- Albinism, albino E70.30
ICD-10-CM Diagnosis Code E70.30
Albinism, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
ICD-10-CM Codes Adjacent To E70.329
E70.311 Autosomal recessive ocular albinism
E70.32 Oculocutaneous albinism
E70.320 Tyrosinase negative oculocutaneous albinism
E70.321 Tyrosinase positive oculocutaneous albinism
E70.328 Other oculocutaneous albinism
E70.329
…… unspecified
E70.33 Albinism with hematologic abnormality
E70.338 Other albinism with hematologic abnormality
E70.39 Other specified albinism
E70.4 Disorders of histidine metabolism
E70.49 Other disorders of histidine metabolism
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
